MX2023005452A - Deteccion de beta amiloide por espectrometria de masas. - Google Patents
Deteccion de beta amiloide por espectrometria de masas.Info
- Publication number
- MX2023005452A MX2023005452A MX2023005452A MX2023005452A MX2023005452A MX 2023005452 A MX2023005452 A MX 2023005452A MX 2023005452 A MX2023005452 A MX 2023005452A MX 2023005452 A MX2023005452 A MX 2023005452A MX 2023005452 A MX2023005452 A MX 2023005452A
- Authority
- MX
- Mexico
- Prior art keywords
- amyloid beta
- mass spectrometry
- methods
- beta detection
- detection
- Prior art date
Links
- 108010090849 Amyloid beta-Peptides Proteins 0.000 title abstract 3
- 102000013455 Amyloid beta-Peptides Human genes 0.000 title abstract 3
- 238000001514 detection method Methods 0.000 title abstract 2
- 238000004949 mass spectrometry Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 4
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 108010064397 amyloid beta-protein (1-40) Proteins 0.000 abstract 1
- 108010064539 amyloid beta-protein (1-42) Proteins 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4709—Amyloid plaque core protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Se proporcionan métodos para la detección o cuantificación de beta amiloide. En un aspecto particular, se proporcionan métodos para la detección de beta amiloide o sus fragmentos mediante espectrometría de masas. En otro aspecto, se proporcionan métodos para determinar la relación de beta amiloide 42 (Aß42) a beta amiloide 40 (Aß40). En otro aspecto, se proporcionan métodos para el diagnóstico o pronóstico de la enfermedad de Alzheimer o demencia.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562234027P | 2015-09-28 | 2015-09-28 | |
| US201662277772P | 2016-01-12 | 2016-01-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023005452A true MX2023005452A (es) | 2023-05-26 |
Family
ID=58407005
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018004017A MX2018004017A (es) | 2015-09-28 | 2016-09-28 | Deteccion de beta amiloide por espectrometria de masas. |
| MX2023005452A MX2023005452A (es) | 2015-09-28 | 2018-03-28 | Deteccion de beta amiloide por espectrometria de masas. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018004017A MX2018004017A (es) | 2015-09-28 | 2016-09-28 | Deteccion de beta amiloide por espectrometria de masas. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11360098B2 (es) |
| EP (2) | EP4275777A3 (es) |
| JP (3) | JP6979401B2 (es) |
| CN (2) | CN117761323A (es) |
| BR (1) | BR112018006018A2 (es) |
| CA (1) | CA3000178C (es) |
| MX (2) | MX2018004017A (es) |
| WO (1) | WO2017058895A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11360098B2 (en) * | 2015-09-28 | 2022-06-14 | Quest Diagnostics Investments Llc | Amyloid beta detection by mass spectrometry |
| WO2019028080A1 (en) * | 2017-07-31 | 2019-02-07 | Quest Diagnostics Investments Llc | DETECTION OF THE ISOTYPE OF APOLIPOPROTEIN E BY MASS SPECTROMETRY |
| CN109045311B (zh) * | 2018-08-29 | 2021-07-20 | 王金环 | 普鲁士蓝纳米mri示踪剂及其制备方法和应用 |
| CN110045046A (zh) * | 2019-03-28 | 2019-07-23 | 东莞市中鼎检测技术有限公司 | 一种生鲜食材的预处理方法及氨基酸含量测定方法 |
| CN110441428B (zh) * | 2019-08-19 | 2021-08-24 | 江南大学 | 一种快速分析蛋白质及强极性长氨基酸序列糖肽的方法 |
| CN113527459B (zh) * | 2021-06-28 | 2023-07-11 | 广州睿徕医学诊断技术有限公司 | 一种萃取剂及其制备方法与应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4774175A (en) * | 1985-03-01 | 1988-09-27 | Centocor, Inc. | Immunochemical methods for the detection of antibody against HTLV-III |
| US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
| DE69432791T2 (de) | 1993-05-28 | 2004-06-03 | Baylor College Of Medicine, Houston | Verfahren und massenspektrometer zur desorption und ionisierung von analyten |
| US5772874A (en) | 1995-11-02 | 1998-06-30 | Cohesive Technologies, Inc. | High performance liquid chromatography method and apparatus |
| JP3452936B2 (ja) | 1996-01-19 | 2003-10-06 | コヒースィヴ テクノロジーズ，インク． | 高速液体クロマトグラフィー法および装置 |
| GB9717926D0 (en) | 1997-08-22 | 1997-10-29 | Micromass Ltd | Methods and apparatus for tandem mass spectrometry |
| WO1999038194A1 (en) | 1998-01-23 | 1999-07-29 | Analytica Of Branford, Inc. | Mass spectrometry from surfaces |
| WO2000017328A2 (en) * | 1998-09-21 | 2000-03-30 | Isis Innovation Limited | Fibrils |
| US20040226056A1 (en) * | 1998-12-22 | 2004-11-11 | Myriad Genetics, Incorporated | Compositions and methods for treating neurological disorders and diseases |
| SE0103084D0 (sv) | 2001-09-14 | 2001-09-14 | Amersham Pharm Biotech Ab | Generation of ion exchange media |
| US20040096907A1 (en) | 2002-11-06 | 2004-05-20 | Bernd Bohrmann | Quantification of beta amyloid |
| CN101374555B (zh) * | 2005-04-06 | 2013-04-17 | 圣路易斯华盛顿州立大学 | 神经衍生的生物分子体内代谢的检测方法 |
| JP2008547003A (ja) * | 2005-06-16 | 2008-12-25 | バーミリオン， インコーポレイテッド | アルツハイマー病についてのバイオマーカーとしての神経分泌タンパク質ｖｇｆのフラグメント |
| US20070134802A1 (en) * | 2005-06-30 | 2007-06-14 | Heinz Doebeli | Ionization modifier for mass spectrometry |
| EP1907423A4 (en) * | 2005-07-13 | 2010-01-13 | Coimmune Inc | CATALYTIC IMMUNOGLOBULINS |
| US9377465B2 (en) | 2007-09-18 | 2016-06-28 | Dako Denmark A/S | Rapid and sensitive method for detection of biological targets |
| US20090142766A1 (en) * | 2007-11-09 | 2009-06-04 | Washington University In St. Louis | Methods for measuring the metabolism of cns derived biomolecules in vivo |
| JP5080945B2 (ja) * | 2007-11-09 | 2012-11-21 | 株式会社日立ハイテクノロジーズ | 質量分析装置および質量分析方法 |
| US8916385B2 (en) | 2007-12-13 | 2014-12-23 | Quest Diagnostics Investments, Inc. | Methods for detecting estrone by mass spectrometry |
| AU2014265047A1 (en) * | 2008-11-12 | 2014-12-11 | The Washington University | Simultaneous measurement of the in vivo metabolism of isoforms of a biomolecule |
| WO2010065878A1 (en) | 2008-12-05 | 2010-06-10 | C2N Diagnostics | Methods for measuring concentrations of biomolecules |
| US9551721B2 (en) * | 2009-06-02 | 2017-01-24 | The Board Of Regents Of The University Of Texas System | Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases |
| US20130137120A1 (en) | 2010-01-28 | 2013-05-30 | Panasonic Corporation | Amyloid b measurement method |
| DE102010026094B4 (de) * | 2010-07-05 | 2012-01-12 | Sigeng Han | Ein neues Verfahren zum Charakterisieren und multidimensionalen Darstellen des Faltungsvorgangs der Proteine |
| HUE055674T2 (hu) | 2010-10-29 | 2021-12-28 | Thermo Fisher Scientific Oy | Rendszerelrendezés automatizált mintaelõkészítõ és -elemzõ rendszerhez |
| BR112014014960A2 (pt) | 2011-12-19 | 2017-06-13 | Univ Washington | métodos para o diagnóstico da doença de alzheimer |
| US11360098B2 (en) * | 2015-09-28 | 2022-06-14 | Quest Diagnostics Investments Llc | Amyloid beta detection by mass spectrometry |
-
2016
- 2016-09-27 US US15/277,879 patent/US11360098B2/en active Active
- 2016-09-28 WO PCT/US2016/054148 patent/WO2017058895A1/en active Application Filing
- 2016-09-28 MX MX2018004017A patent/MX2018004017A/es unknown
- 2016-09-28 BR BR112018006018A patent/BR112018006018A2/pt active Search and Examination
- 2016-09-28 JP JP2018515954A patent/JP6979401B2/ja active Active
- 2016-09-28 CN CN202311809070.7A patent/CN117761323A/zh active Pending
- 2016-09-28 EP EP23187203.7A patent/EP4275777A3/en active Pending
- 2016-09-28 EP EP16852474.2A patent/EP3356831B1/en active Active
- 2016-09-28 CN CN201680068333.5A patent/CN108291916B/zh active Active
- 2016-09-28 CA CA3000178A patent/CA3000178C/en active Active
-
2018
- 2018-03-28 MX MX2023005452A patent/MX2023005452A/es unknown
-
2021
- 2021-08-06 JP JP2021129885A patent/JP7407776B2/ja active Active
-
2022
- 2022-06-13 US US17/839,262 patent/US20220349897A1/en active Pending
-
2023
- 2023-12-19 JP JP2023214277A patent/JP2024050535A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US11360098B2 (en) | 2022-06-14 |
| MX2018004017A (es) | 2018-06-27 |
| JP2018535398A (ja) | 2018-11-29 |
| BR112018006018A2 (pt) | 2018-11-06 |
| JP6979401B2 (ja) | 2021-12-15 |
| US20170089917A1 (en) | 2017-03-30 |
| EP4275777A3 (en) | 2024-01-10 |
| EP3356831A1 (en) | 2018-08-08 |
| CA3000178A1 (en) | 2017-04-06 |
| WO2017058895A1 (en) | 2017-04-06 |
| EP3356831B1 (en) | 2023-09-27 |
| JP2021192038A (ja) | 2021-12-16 |
| EP3356831A4 (en) | 2019-08-21 |
| JP7407776B2 (ja) | 2024-01-04 |
| CN108291916A (zh) | 2018-07-17 |
| EP4275777A2 (en) | 2023-11-15 |
| CN117761323A (zh) | 2024-03-26 |
| CN108291916B (zh) | 2024-01-02 |
| US20220349897A1 (en) | 2022-11-03 |
| JP2024050535A (ja) | 2024-04-10 |
| CA3000178C (en) | 2022-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023005452A (es) | Deteccion de beta amiloide por espectrometria de masas. | |
| WO2015061634A3 (en) | Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders | |
| MY194686A (en) | Detection of chromosome interactions | |
| IL294121A (en) | An RNA test to diagnose the type of infection | |
| MX337535B (es) | Anticuerpo, kit y metodo para la determinacion de peptidos amiloides. | |
| WO2014160499A3 (en) | Methods and compositions for detecting pancreatic cancer | |
| MX340453B (es) | Biomarcadores para cancer de pulmon. | |
| EP3175242A4 (en) | Quantifying monoclonal antibody therapeutics by lc-ms/ms | |
| WO2014207049A3 (de) | Verfahren zur bestimmung von proteinaggregaten unter verwendung von oberflächen-fida | |
| EP3633372A4 (en) | BIOMARKERS FOR ALZHEIMER'S MORBUS | |
| EP3690063A3 (en) | Diagnosis of lung cancer | |
| MX2018005448A (es) | Metodos para la deteccion de apolipoproteinas. | |
| EP3438277A4 (en) | PROCESS FOR DETERMINING WHETHER A TEST PROCEDURE CONTAINS PHYTOPATHOGENIC MUSHROOMS OR NOT | |
| EP3221704A4 (en) | Detecting dementia and alzheimer's disease associated biomarkers stabilized on solid support materials | |
| WO2017029401A8 (en) | Means and methods for diagnosing cardiac disease in a subject | |
| WO2015006686A8 (en) | Elucidation of ion exchange chromatography input optimization | |
| EP3345000A4 (en) | NOVEL BIOMARKER FOR BLOOD CELLS FOR ALZHEIMER'S DISEASE AT LATE SIDE | |
| MX363679B (es) | Metodo para diagnosticar cancer. | |
| EP3254300A4 (en) | Detecting mass spectrometry based similarity via curve subtraction | |
| WO2015068075A3 (en) | Detection of tau | |
| EP3390700A4 (en) | ANTIBODY BIOMARKERS FOR MORBUS ALZHEIMER IN THE EARLY STADIUM, TARGETED AND DIAGNOSTIC USES THEREOF | |
| WO2014181215A3 (en) | Method for determining free copper | |
| EP3254112A4 (en) | Formulations comprising mercury-containing reagents for detecting disease | |
| WO2016027029A3 (fr) | Procédé pour déterminer le pronostic de survie d'un patient atteint d'un cancer du pancréas | |
| EP3642366C0 (en) | CIRCULATING SERUM MICRORNA BIOMARKERS AND METHODS FOR DIAGNOSING ALZHEIMER’S DISEASE |